|
|
|
|
|
by ekianjo
1441 days ago
|
|
Wrong on all accounts. The early communication about the vaccine was all about preventing infections. You are trying to rewrite History. Back in 2020, press release from Pfizer: https://www.pfizer.com/news/press-release/press-release-deta... > "Primary efficacy analysis demonstrates BNT162b2 to be 95% effective against COVID-19 beginning 28 days after the first dose;170 confirmed cases of COVID-19 were evaluated, with 162 observed in the placebo group versus 8 in the vaccine group. Efficacy was consistent across age, gender, race and ethnicity demographics; observed efficacy in adults over 65 years of age was over 94%" |
|